Table of Content

1 CD1d Antibody Market Overview
1.1 Product Overview and Scope of CD1d Antibody
1.2 CD1d Antibody Segment by Type
1.2.1 Global CD1d Antibody Market Value Comparison by Type (2023-2033)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD1d Antibody Segment by Application
1.3.1 Global CD1d Antibody Market Value by Application: (2023-2033)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD1d Antibody Market Size Estimates and Forecasts
1.4.1 Global CD1d Antibody Revenue 2018-2033
1.4.2 Global CD1d Antibody Sales 2018-2033
1.4.3 Global CD1d Antibody Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 CD1d Antibody Market Competition by Manufacturers
2.1 Global CD1d Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global CD1d Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global CD1d Antibody Average Price by Manufacturers (2018-2023)
2.4 Global CD1d Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of CD1d Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD1d Antibody, Product Type & Application
2.7 CD1d Antibody Market Competitive Situation and Trends
2.7.1 CD1d Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD1d Antibody Players Market Share by Revenue
2.7.3 Global CD1d Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD1d Antibody Retrospective Market Scenario by Region
3.1 Global CD1d Antibody Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global CD1d Antibody Global CD1d Antibody Sales by Region: 2018-2033
3.2.1 Global CD1d Antibody Sales by Region: 2018-2023
3.2.2 Global CD1d Antibody Sales by Region: 2024-2033
3.3 Global CD1d Antibody Global CD1d Antibody Revenue by Region: 2018-2033
3.3.1 Global CD1d Antibody Revenue by Region: 2018-2023
3.3.2 Global CD1d Antibody Revenue by Region: 2024-2033
3.4 North America CD1d Antibody Market Facts & Figures by Country
3.4.1 North America CD1d Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America CD1d Antibody Sales by Country (2018-2033)
3.4.3 North America CD1d Antibody Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD1d Antibody Market Facts & Figures by Country
3.5.1 Europe CD1d Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe CD1d Antibody Sales by Country (2018-2033)
3.5.3 Europe CD1d Antibody Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD1d Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific CD1d Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific CD1d Antibody Sales by Country (2018-2033)
3.6.3 Asia Pacific CD1d Antibody Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD1d Antibody Market Facts & Figures by Country
3.7.1 Latin America CD1d Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America CD1d Antibody Sales by Country (2018-2033)
3.7.3 Latin America CD1d Antibody Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa CD1d Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD1d Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa CD1d Antibody Sales by Country (2018-2033)
3.8.3 Middle East and Africa CD1d Antibody Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD1d Antibody Sales by Type (2018-2033)
4.1.1 Global CD1d Antibody Sales by Type (2018-2023)
4.1.2 Global CD1d Antibody Sales by Type (2024-2033)
4.1.3 Global CD1d Antibody Sales Market Share by Type (2018-2033)
4.2 Global CD1d Antibody Revenue by Type (2018-2033)
4.2.1 Global CD1d Antibody Revenue by Type (2018-2023)
4.2.2 Global CD1d Antibody Revenue by Type (2024-2033)
4.2.3 Global CD1d Antibody Revenue Market Share by Type (2018-2033)
4.3 Global CD1d Antibody Price by Type (2018-2033)
5 Segment by Application
5.1 Global CD1d Antibody Sales by Application (2018-2033)
5.1.1 Global CD1d Antibody Sales by Application (2018-2023)
5.1.2 Global CD1d Antibody Sales by Application (2024-2033)
5.1.3 Global CD1d Antibody Sales Market Share by Application (2018-2033)
5.2 Global CD1d Antibody Revenue by Application (2018-2033)
5.2.1 Global CD1d Antibody Revenue by Application (2018-2023)
5.2.2 Global CD1d Antibody Revenue by Application (2024-2033)
5.2.3 Global CD1d Antibody Revenue Market Share by Application (2018-2033)
5.3 Global CD1d Antibody Price by Application (2018-2033)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific CD1d Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Leinco Technologies
6.2.1 Leinco Technologies Corporation Information
6.2.2 Leinco Technologies Description and Business Overview
6.2.3 Leinco Technologies CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Leinco Technologies CD1d Antibody Product Portfolio
6.2.5 Leinco Technologies Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Corporation Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Biosciences CD1d Antibody Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 Proteintech Group
6.4.1 Proteintech Group Corporation Information
6.4.2 Proteintech Group Description and Business Overview
6.4.3 Proteintech Group CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Proteintech Group CD1d Antibody Product Portfolio
6.4.5 Proteintech Group Recent Developments/Updates
6.5 LifeSpan BioSciences
6.5.1 LifeSpan BioSciences Corporation Information
6.5.2 LifeSpan BioSciences Description and Business Overview
6.5.3 LifeSpan BioSciences CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LifeSpan BioSciences CD1d Antibody Product Portfolio
6.5.5 LifeSpan BioSciences Recent Developments/Updates
6.6 RayBiotech
6.6.1 RayBiotech Corporation Information
6.6.2 RayBiotech Description and Business Overview
6.6.3 RayBiotech CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 RayBiotech CD1d Antibody Product Portfolio
6.6.5 RayBiotech Recent Developments/Updates
6.7 BioLegend
6.6.1 BioLegend Corporation Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioLegend CD1d Antibody Product Portfolio
6.7.5 BioLegend Recent Developments/Updates
6.8 GeneTex
6.8.1 GeneTex Corporation Information
6.8.2 GeneTex Description and Business Overview
6.8.3 GeneTex CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GeneTex CD1d Antibody Product Portfolio
6.8.5 GeneTex Recent Developments/Updates
6.9 Leading Biology
6.9.1 Leading Biology Corporation Information
6.9.2 Leading Biology Description and Business Overview
6.9.3 Leading Biology CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Leading Biology CD1d Antibody Product Portfolio
6.9.5 Leading Biology Recent Developments/Updates
6.10 ProSci
6.10.1 ProSci Corporation Information
6.10.2 ProSci Description and Business Overview
6.10.3 ProSci CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ProSci CD1d Antibody Product Portfolio
6.10.5 ProSci Recent Developments/Updates
6.11 Bethyl Laboratories
6.11.1 Bethyl Laboratories Corporation Information
6.11.2 Bethyl Laboratories CD1d Antibody Description and Business Overview
6.11.3 Bethyl Laboratories CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Bethyl Laboratories CD1d Antibody Product Portfolio
6.11.5 Bethyl Laboratories Recent Developments/Updates
6.12 Novus Biologicals
6.12.1 Novus Biologicals Corporation Information
6.12.2 Novus Biologicals CD1d Antibody Description and Business Overview
6.12.3 Novus Biologicals CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Novus Biologicals CD1d Antibody Product Portfolio
6.12.5 Novus Biologicals Recent Developments/Updates
6.13 OriGene Technologies
6.13.1 OriGene Technologies Corporation Information
6.13.2 OriGene Technologies CD1d Antibody Description and Business Overview
6.13.3 OriGene Technologies CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 OriGene Technologies CD1d Antibody Product Portfolio
6.13.5 OriGene Technologies Recent Developments/Updates
6.14 NSJ Bioreagents
6.14.1 NSJ Bioreagents Corporation Information
6.14.2 NSJ Bioreagents CD1d Antibody Description and Business Overview
6.14.3 NSJ Bioreagents CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 NSJ Bioreagents CD1d Antibody Product Portfolio
6.14.5 NSJ Bioreagents Recent Developments/Updates
6.15 BosterBio
6.15.1 BosterBio Corporation Information
6.15.2 BosterBio CD1d Antibody Description and Business Overview
6.15.3 BosterBio CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 BosterBio CD1d Antibody Product Portfolio
6.15.5 BosterBio Recent Developments/Updates
6.16 ABclonal Technology
6.16.1 ABclonal Technology Corporation Information
6.16.2 ABclonal Technology CD1d Antibody Description and Business Overview
6.16.3 ABclonal Technology CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ABclonal Technology CD1d Antibody Product Portfolio
6.16.5 ABclonal Technology Recent Developments/Updates
6.17 R&D Systems
6.17.1 R&D Systems Corporation Information
6.17.2 R&D Systems CD1d Antibody Description and Business Overview
6.17.3 R&D Systems CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 R&D Systems CD1d Antibody Product Portfolio
6.17.5 R&D Systems Recent Developments/Updates
6.18 St John's Laboratory
6.18.1 St John's Laboratory Corporation Information
6.18.2 St John's Laboratory CD1d Antibody Description and Business Overview
6.18.3 St John's Laboratory CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 St John's Laboratory CD1d Antibody Product Portfolio
6.18.5 St John's Laboratory Recent Developments/Updates
6.19 CUSABIO Technology
6.19.1 CUSABIO Technology Corporation Information
6.19.2 CUSABIO Technology CD1d Antibody Description and Business Overview
6.19.3 CUSABIO Technology CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 CUSABIO Technology CD1d Antibody Product Portfolio
6.19.5 CUSABIO Technology Recent Developments/Updates
6.20 Wuhan Fine
6.20.1 Wuhan Fine Corporation Information
6.20.2 Wuhan Fine CD1d Antibody Description and Business Overview
6.20.3 Wuhan Fine CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Wuhan Fine CD1d Antibody Product Portfolio
6.20.5 Wuhan Fine Recent Developments/Updates
6.21 Biobyt
6.21.1 Biobyt Corporation Information
6.21.2 Biobyt CD1d Antibody Description and Business Overview
6.21.3 Biobyt CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Biobyt CD1d Antibody Product Portfolio
6.21.5 Biobyt Recent Developments/Updates
6.22 Jingjie PTM BioLab
6.22.1 Jingjie PTM BioLab Corporation Information
6.22.2 Jingjie PTM BioLab CD1d Antibody Description and Business Overview
6.22.3 Jingjie PTM BioLab CD1d Antibody Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Jingjie PTM BioLab CD1d Antibody Product Portfolio
6.22.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD1d Antibody Industry Chain Analysis
7.2 CD1d Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD1d Antibody Production Mode & Process
7.4 CD1d Antibody Sales and Marketing
7.4.1 CD1d Antibody Sales Channels
7.4.2 CD1d Antibody Distributors
7.5 CD1d Antibody Customers
8 CD1d Antibody Market Dynamics
8.1 CD1d Antibody Industry Trends
8.2 CD1d Antibody Market Drivers
8.3 CD1d Antibody Market Challenges
8.4 CD1d Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global CD1d Antibody Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global CD1d Antibody Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global CD1d Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global CD1d Antibody Sales (ml) of Key Manufacturers (2018-2023)
Table 5. Global CD1d Antibody Sales Market Share by Manufacturers (2018-2023)
Table 6. Global CD1d Antibody Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global CD1d Antibody Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market CD1d Antibody Average Price (US$/ml) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of CD1d Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of CD1d Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD1d Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD1d Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD1d Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD1d Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD1d Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global CD1d Antibody Sales by Region (2018-2023) & (ml)
Table 18. Global CD1d Antibody Sales Market Share by Region (2018-2023)
Table 19. Global CD1d Antibody Sales by Region (2024-2033) & (ml)
Table 20. Global CD1d Antibody Sales Market Share by Region (2024-2033)
Table 21. Global CD1d Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global CD1d Antibody Revenue Market Share by Region (2018-2023)
Table 23. Global CD1d Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global CD1d Antibody Revenue Market Share by Region (2024-2033)
Table 25. North America CD1d Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America CD1d Antibody Sales by Country (2018-2023) & (ml)
Table 27. North America CD1d Antibody Sales by Country (2024-2033) & (ml)
Table 28. North America CD1d Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America CD1d Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe CD1d Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe CD1d Antibody Sales by Country (2018-2023) & (ml)
Table 32. Europe CD1d Antibody Sales by Country (2024-2033) & (ml)
Table 33. Europe CD1d Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe CD1d Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific CD1d Antibody Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific CD1d Antibody Sales by Region (2018-2023) & (ml)
Table 37. Asia Pacific CD1d Antibody Sales by Region (2024-2033) & (ml)
Table 38. Asia Pacific CD1d Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific CD1d Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America CD1d Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America CD1d Antibody Sales by Country (2018-2023) & (ml)
Table 42. Latin America CD1d Antibody Sales by Country (2024-2033) & (ml)
Table 43. Latin America CD1d Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America CD1d Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa CD1d Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa CD1d Antibody Sales by Country (2018-2023) & (ml)
Table 47. Middle East & Africa CD1d Antibody Sales by Country (2024-2033) & (ml)
Table 48. Middle East & Africa CD1d Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa CD1d Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global CD1d Antibody Sales (ml) by Type (2018-2023)
Table 51. Global CD1d Antibody Sales (ml) by Type (2024-2033)
Table 52. Global CD1d Antibody Sales Market Share by Type (2018-2023)
Table 53. Global CD1d Antibody Sales Market Share by Type (2024-2033)
Table 54. Global CD1d Antibody Revenue (US$ Million) by Type (2018-2023)
Table 55. Global CD1d Antibody Revenue (US$ Million) by Type (2024-2033)
Table 56. Global CD1d Antibody Revenue Market Share by Type (2018-2023)
Table 57. Global CD1d Antibody Revenue Market Share by Type (2024-2033)
Table 58. Global CD1d Antibody Price (US$/ml) by Type (2018-2023)
Table 59. Global CD1d Antibody Price (US$/ml) by Type (2024-2033)
Table 60. Global CD1d Antibody Sales (ml) by Application (2018-2023)
Table 61. Global CD1d Antibody Sales (ml) by Application (2024-2033)
Table 62. Global CD1d Antibody Sales Market Share by Application (2018-2023)
Table 63. Global CD1d Antibody Sales Market Share by Application (2024-2033)
Table 64. Global CD1d Antibody Revenue (US$ Million) by Application (2018-2023)
Table 65. Global CD1d Antibody Revenue (US$ Million) by Application (2024-2033)
Table 66. Global CD1d Antibody Revenue Market Share by Application (2018-2023)
Table 67. Global CD1d Antibody Revenue Market Share by Application (2024-2033)
Table 68. Global CD1d Antibody Price (US$/ml) by Application (2018-2023)
Table 69. Global CD1d Antibody Price (US$/ml) by Application (2024-2033)
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 73. Thermo Fisher Scientific CD1d Antibody Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Leinco Technologies Corporation Information
Table 76. Leinco Technologies Description and Business Overview
Table 77. Leinco Technologies CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 78. Leinco Technologies CD1d Antibody Product
Table 79. Leinco Technologies Recent Developments/Updates
Table 80. BD Biosciences Corporation Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 83. BD Biosciences CD1d Antibody Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. Proteintech Group Corporation Information
Table 86. Proteintech Group Description and Business Overview
Table 87. Proteintech Group CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 88. Proteintech Group CD1d Antibody Product
Table 89. Proteintech Group Recent Developments/Updates
Table 90. LifeSpan BioSciences Corporation Information
Table 91. LifeSpan BioSciences Description and Business Overview
Table 92. LifeSpan BioSciences CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 93. LifeSpan BioSciences CD1d Antibody Product
Table 94. LifeSpan BioSciences Recent Developments/Updates
Table 95. RayBiotech Corporation Information
Table 96. RayBiotech Description and Business Overview
Table 97. RayBiotech CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 98. RayBiotech CD1d Antibody Product
Table 99. RayBiotech Recent Developments/Updates
Table 100. BioLegend Corporation Information
Table 101. BioLegend Description and Business Overview
Table 102. BioLegend CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 103. BioLegend CD1d Antibody Product
Table 104. BioLegend Recent Developments/Updates
Table 105. GeneTex Corporation Information
Table 106. GeneTex Description and Business Overview
Table 107. GeneTex CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 108. GeneTex CD1d Antibody Product
Table 109. GeneTex Recent Developments/Updates
Table 110. Leading Biology Corporation Information
Table 111. Leading Biology Description and Business Overview
Table 112. Leading Biology CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 113. Leading Biology CD1d Antibody Product
Table 114. Leading Biology Recent Developments/Updates
Table 115. ProSci Corporation Information
Table 116. ProSci Description and Business Overview
Table 117. ProSci CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 118. ProSci CD1d Antibody Product
Table 119. ProSci Recent Developments/Updates
Table 120. Bethyl Laboratories Corporation Information
Table 121. Bethyl Laboratories Description and Business Overview
Table 122. Bethyl Laboratories CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 123. Bethyl Laboratories CD1d Antibody Product
Table 124. Bethyl Laboratories Recent Developments/Updates
Table 125. Novus Biologicals Corporation Information
Table 126. Novus Biologicals Description and Business Overview
Table 127. Novus Biologicals CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 128. Novus Biologicals CD1d Antibody Product
Table 129. Novus Biologicals Recent Developments/Updates
Table 130. OriGene Technologies Corporation Information
Table 131. OriGene Technologies Description and Business Overview
Table 132. OriGene Technologies CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 133. OriGene Technologies CD1d Antibody Product
Table 134. OriGene Technologies Recent Developments/Updates
Table 135. NSJ Bioreagents Corporation Information
Table 136. NSJ Bioreagents Description and Business Overview
Table 137. NSJ Bioreagents CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 138. NSJ Bioreagents CD1d Antibody Product
Table 139. NSJ Bioreagents Recent Developments/Updates
Table 140. BosterBio Corporation Information
Table 141. BosterBio Description and Business Overview
Table 142. BosterBio CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 143. BosterBio CD1d Antibody Product
Table 144. BosterBio Recent Developments/Updates
Table 145. ABclonal Technology Corporation Information
Table 146. ABclonal Technology Description and Business Overview
Table 147. ABclonal Technology CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 148. ABclonal Technology CD1d Antibody Product
Table 149. ABclonal Technology Recent Developments/Updates
Table 150. R&D Systems Corporation Information
Table 151. R&D Systems Description and Business Overview
Table 152. R&D Systems CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 153. R&D Systems CD1d Antibody Product
Table 154. R&D Systems Recent Developments/Updates
Table 155. St John's Laboratory Corporation Information
Table 156. St John's Laboratory Description and Business Overview
Table 157. St John's Laboratory CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 158. St John's Laboratory CD1d Antibody Product
Table 159. St John's Laboratory Recent Developments/Updates
Table 160. CUSABIO Technology Corporation Information
Table 161. CUSABIO Technology Description and Business Overview
Table 162. CUSABIO Technology CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 163. CUSABIO Technology CD1d Antibody Product
Table 164. CUSABIO Technology Recent Developments/Updates
Table 165. Wuhan Fine Corporation Information
Table 166. Wuhan Fine Description and Business Overview
Table 167. Wuhan Fine CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 168. Wuhan Fine CD1d Antibody Product
Table 169. Wuhan Fine Recent Developments/Updates
Table 170. Biobyt Corporation Information
Table 171. Biobyt Description and Business Overview
Table 172. Biobyt CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 173. Biobyt CD1d Antibody Product
Table 174. Biobyt Recent Developments/Updates
Table 175. Jingjie PTM BioLab Corporation Information
Table 176. Jingjie PTM BioLab Description and Business Overview
Table 177. Jingjie PTM BioLab CD1d Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 178. Jingjie PTM BioLab CD1d Antibody Product
Table 179. Jingjie PTM BioLab Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. CD1d Antibody Distributors List
Table 183. CD1d Antibody Customers List
Table 184. CD1d Antibody Market Trends
Table 185. CD1d Antibody Market Drivers
Table 186. CD1d Antibody Market Challenges
Table 187. CD1d Antibody Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CD1d Antibody
Figure 2. Global CD1d Antibody Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global CD1d Antibody Market Share by Type in 2022 & 2033
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD1d Antibody Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global CD1d Antibody Market Share by Application in 2022 & 2033
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD1d Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global CD1d Antibody Market Size (2018-2033) & (US$ Million)
Figure 16. Global CD1d Antibody Sales (2018-2033) & (ml)
Figure 17. Global CD1d Antibody Average Price (US$/ml) & (2018-2033)
Figure 18. CD1d Antibody Report Years Considered
Figure 19. CD1d Antibody Sales Share by Manufacturers in 2022
Figure 20. Global CD1d Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest CD1d Antibody Players: Market Share by Revenue in 2022
Figure 22. CD1d Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global CD1d Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 24. North America CD1d Antibody Sales Market Share by Country (2018-2033)
Figure 25. North America CD1d Antibody Revenue Market Share by Country (2018-2033)
Figure 26. United States CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 27. Canada CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. Europe CD1d Antibody Sales Market Share by Country (2018-2033)
Figure 29. Europe CD1d Antibody Revenue Market Share by Country (2018-2033)
Figure 30. Germany CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. France CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. U.K. CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. Italy CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Russia CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. Asia Pacific CD1d Antibody Sales Market Share by Region (2018-2033)
Figure 36. Asia Pacific CD1d Antibody Revenue Market Share by Region (2018-2033)
Figure 37. China CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. Japan CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. South Korea CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. India CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. Australia CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Taiwan CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Southeast Asia CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Latin America CD1d Antibody Sales Market Share by Country (2018-2033)
Figure 45. Latin America CD1d Antibody Revenue Market Share by Country (2018-2033)
Figure 46. Mexico CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 47. Brazil CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Argentina CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Colombia CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa CD1d Antibody Sales Market Share by Country (2018-2033)
Figure 51. Middle East & Africa CD1d Antibody Revenue Market Share by Country (2018-2033)
Figure 52. Turkey CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. UAE CD1d Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 55. Global Sales Market Share of CD1d Antibody by Type (2018-2033)
Figure 56. Global Revenue Market Share of CD1d Antibody by Type (2018-2033)
Figure 57. Global CD1d Antibody Price (US$/ml) by Type (2018-2033)
Figure 58. Global Sales Market Share of CD1d Antibody by Application (2018-2033)
Figure 59. Global Revenue Market Share of CD1d Antibody by Application (2018-2033)
Figure 60. Global CD1d Antibody Price (US$/ml) by Application (2018-2033)
Figure 61. CD1d Antibody Value Chain
Figure 62. CD1d Antibody Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed